Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
Clinical trial NCT01201837 · COMPLETED
Trial details
- NCT number
- NCT01201837
- Sponsor
- Cerenis Therapeutics, SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.